News for hackers. Stuff that matters.
Re:23andMe has signed a $300M deal with GlaxoSmithKline by lakeeffect on Saturday January 05, 2019 @10:38AM (#18832130)
The article says it's opt-out not opt-in, and purpose is to find drug targets and clinical trail participants.

There are no comments on this comment yet.